Compare CLPT & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLPT | ASPI |
|---|---|---|
| Founded | 1998 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 467.9M | 507.5M |
| IPO Year | 2009 | 2022 |
| Metric | CLPT | ASPI |
|---|---|---|
| Price | $9.15 | $1.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $23.50 | $13.00 |
| AVG Volume (30 Days) | 649.3K | ★ 4.5M |
| Earning Date | 10-28-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $36,971,000.00 | $23,849,000.00 |
| Revenue This Year | $32.54 | N/A |
| Revenue Next Year | $15.41 | $189.67 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 17.78 | ★ 475.48 |
| 52 Week Low | $8.27 | $1.89 |
| 52 Week High | $27.27 | $11.22 |
| Indicator | CLPT | ASPI |
|---|---|---|
| Relative Strength Index (RSI) | 31.63 | 28.21 |
| Support Level | $8.61 | N/A |
| Resistance Level | $15.30 | $3.06 |
| Average True Range (ATR) | 0.48 | 0.19 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 5.20 | 4.50 |
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
ASP Isotopes Inc is a materials company focused on producing and commercializing enriched isotopes for the nuclear medicine, healthcare, green energy, and quantum computing industries. Currently, the company has three operating segments: (i) nuclear fuels, (ii) specialist isotopes and related services, and (iii) construction services. Using proprietary technology-the Aerodynamic Separation Process (ASP)-the company enriches isotopes in South Africa, targeting high-value, low-volume markets to reduce reliance on foreign supply chains. Geographically, the company operates in South Africa, Hong Kong and United States generating key revenue from the Hong Kong region.